The PennZone

  • Home
  • Non-profit
  • Business
  • Entertainment
  • Construction
  • Technology
  • Education
  • Real Estate
  • Celebrities

Olympus Acquires Veran Medical Technologies, Inc.
The PennZone/10102444

Trending...
  • From Speech Therapy to 300+ Episodes: Brother Marcus Turns His Voice Into a Movement Launching a 24/7 Inspiration Radio Network on Day 100 of the Year
  • Porter's Day Care Empowers Philadelphia's Future Through 45+ Years of Excellence
  • YOKE Expands NIL Club Into Athlete-Led Commerce With Athlete Merch Launch
CENTER VALLEY, Pa. and TOKYO, Dec. 30, 2020 /PRNewswire/ -- Olympus Corporation today announced that it has finalized the acquisition of Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, following the definitive agreement the two companies signed December 4, 2020. With this acquisition by Olympus subsidiary Olympus Corporation of the Americas (OCA), Olympus gains VMT's global sales network, marketing, manufacturing, R&D, and other functions to expand the Olympus respiratory product portfolio.

Lung cancer is the leading cause of cancer-related deaths globally.1 With increased awareness and more lung cancer screenings using low-dose computed tomography (CT), the need for definitive diagnosis of lesions in the peripheral regions of the lungs by tissue biopsy is expected to increase. VMT's SPiN Thoracic Navigation System® and related devices are specifically designed to help physicians navigate to, localize, and sample peripheral pulmonary lesions. Together with the existing Olympus respiratory portfolio that includes radial endobronchial ultrasound (EBUS) and thin bronchoscopes, VMT's navigational system and related devices provide a powerful combination of imaging, access and precision for pulmonologists seeking to diagnose and determine the stage of a patient's lung cancer.

More on The PennZone
  • HarryPotterObamaSonic10Inu (Ticker: BITCOIN) Is the Best Cryptocurrency in Global History
  • Colonial Nissan Highlights 2026 Armada after Major Best Buy Award Win
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • The Finger Comb, a Dream Inspired 3-in-1 Styling Tool introduced by Andrea L. Randolph Introduces
  • Additions of Tennant, Morrissey, Cummings, Hale Highlight Fandoms at FAN EXPO Philadelphia

"We are very excited about the synergies this acquisition creates. With the deal now closed, as one company we are able to combine Olympus' expertise and clinical history in minimally invasive technology with the innovation in navigation systems of Veran Medical Technology to improve workflow and patient care in lung cancer," said Lynn Ray, Vice President and General Manager of the Global Respiratory Business Unit for Olympus Corporation. "Olympus is committed to providing the medical community with the best tools possible to use in their fight against cancer. With the advent of EBUS-guided transbronchial needle aspiration (EBUS-TBNA) in 2004, Olympus brought patients the benefit of more accurate diagnosis and staging, to improve patient outcomes and care. We are thrilled to be at the forefront of development in this rapidly evolving area of respiratory care."

The acquisition will provide immediate incremental revenue and an experienced sales team within the U.S. market. VMT's advanced and proven navigation technology, together with Olympus' respiratory portfolio, strengthens and enhances Olympus' global position as a medical technology innovator.

As part of its current Corporate Strategy, Olympus vowed to "focus and scale" its Therapeutic solutions Division (TSD). To accelerate the process and provide greater agility, Olympus made OCA the TSD headquarters, recognizing the significant growth opportunities in North America. Olympus also identified three core medical fields to prioritize and has since focused on gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.

More on The PennZone
  • GitKraken Desktop 12.0 Introduces Agent Mode: Gives Developers Ultimate Control & Visualization While Scaling Parallel Agent Workflows
  • 5 Things to Check Before Calling for AC Repair in Philly
  • Go Dental Clinic Announces Upcoming Opening of New Branch in International City, Dubai
  • Dog Grooming Businesses Turn to Performance-Based Platforms to Attract Local Clients
  • Hazel E Hosts Starline Tours Bus to Sonic Desert - A Launch to Coachella

For additional information, please refer to our corporate disclosure, "Notice regarding acquisition of Veran Medical Technologies, Inc. in the United States."

(available at: https://www.olympus-global.com/news/ir/2020/)

1 WHO data:  https://www.who.int/news-room/fact-sheets/detail/cancer

About Olympus' Therapeutic Solutions Division
In its Therapeutic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with its early contributions to the development of the polypectomy snare, Olympus' Therapeutic Solutions portfolio has grown to include an array of surgical energy devices and a wide range of instruments to help prevent, detect, and treat disease. For more information, visit www.olympus-global.com.

SOURCE Olympus

Related Links

http://www.olympus.com/
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Grange Insurance Association to Rebrand as Granwest Insurance on July 1, 2026
  • Dr. Rosendo Icochea, MD Recognized for Contributions to Surgical Education and Medical Research
  • Giftella Launches AI Gift-Finder App That Replaces Guesswork With Personalized Picks in Seconds
  • Beverly.io Announces Nationwide Expansion and Poppins Payroll Partnership for Families
  • Collectors gathered 'round the playing circle to compete for the rarest and best examples at Morphy's April 11 Premier Marbles auction
  • New Book: The Battle for Truth and Shadows - Guardians of Light - Epic Fantasy Unveils a War Between Light and Deception
  • Clash of Prompts: The World's First AI Prompt Battle Royale
  • $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
  • MainConcept Announces Multiview Encoding for Apple Immersive Video
  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
  • Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
  • Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
  • Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps
  • RemodelCalculators.com Launches 15 Free Home Renovation Tools
  • InterMountain Management Announces the Re-opening of Holiday Inn Express & Suites Alexandria
  • CB Stuffer Expands New England Footprint with Launch at Common Man Roadside in Hooksett, NH
  • Contracting Resources Group Named to the 2026 Inc. Regionals: Mid-Atlantic List
  • Bishop Mary's WWDB 860 AM Show Nears Historic 250-Episode Milestone
  • Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports

Popular on PennZone

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 226
  • Actress/Model Raelia Lewis Building a Powerful Name in Entertainment and Fashion - 115
  • R&B Artist Mike Davis Announces Debut Full-Length Album Full Circle, Releasing April 7
  • 300 Episodes. One Mission: Brother Marcus Ignites a Global Movement of Inspiration
  • New Report Reveals Surprising Trends in Ohio Airport Accidents
  • Bethany Nikitenko Elected Board Vice President of Philadelphia VIP
  • From Speech Therapy to 300+ Episodes: Brother Marcus Turns His Voice Into a Movement Launching a 24/7 Inspiration Radio Network on Day 100 of the Year
  • The State of Law Firm Marketing: Top Companies, Awards, and Resources
  • IWS Press Publishes "Smart Money Shortcuts to Becoming Rich" by Tyler G. Hicks
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking

Similar on PennZone

  • ULiveUSA Launches New "Moment Marketing" System Using Videos to Help Local Businesses Get More Customers
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Dog Grooming Businesses Turn to Performance-Based Platforms to Attract Local Clients
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us